TC
CORT icon

TFS Capital’s Corcept Therapeutics CORT Stock Holding History

TFS Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,692
Closed -$126K – 75
2017
Q2 		$126K Buy
+10,692
New +$116K 0.05% 524
2017
Q1 		– Sell
-22,111
Closed -$161K – 697
2016
Q4 		$161K Buy
+22,111
New +$173K 0.04% 570
2016
Q3 		– Sell
-150,979
Closed -$824K – 781
2016
Q2 		$824K Buy
150,979
+69,191
+85% +$360K 0.15% 223
2016
Q1 		$383K Sell
81,788
-356,583
-81% -$1.39M 0.06% 552
2015
Q4 		$2.18M Buy
438,371
+120,374
+38% +$543K 0.24% 147
2015
Q3 		$1.2M Buy
317,997
+3,902
+1% +$19.8K 0.12% 294
2015
Q2 		$1.89M Buy
314,095
+301,089
+2,315% +$1.85M 0.18% 157
2015
Q1 		$73K Buy
+13,006
New +$47.1K 0.01% 906
2014
Q4 		– Sell
-49,868
Closed -$134K – 1010
2014
Q3 		$134K Sell
49,868
-102,403
-67% -$271K 0.01% 940
2014
Q2 		$426K Sell
152,271
-350,718
-70% -$1.04M 0.03% 703
2014
Q1 		$2.19M Buy
502,989
+315,066
+168% +$1.1M 0.15% 204
2013
Q4 		$603K Buy
187,923
+42,528
+29% +$86K 0.03% 748
2013
Q3 		$231K Sell
145,395
-159,272
-52% -$281K 0.01% 1204
2013
Q2 		$527K Buy
+304,667
New +$548K 0.02% 873

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TFS Capital's CORT Position: Q3 2017 in Review

TFS Capital sold out of Corcept Therapeutics (CORT) in Q3 2017, closing a stake of 10,692 shares — an estimated $126K sold.

TFS Capital first reported a position in CORT in Q2 2013 and held it in 14 quarters. The position peaked at $2.19M in Q1 2014. 189 funds tracked by Wall St. Rank hold CORT as of Q3 2017.

  • TFS Capital reported no remaining Corcept Therapeutics position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 10,692 Corcept Therapeutics shares in Q3 2017, an estimated $126K.
  • TFS Capital first reported a position in Corcept Therapeutics in Q2 2013 and held it in 14 quarters.
  • TFS Capital's Corcept Therapeutics position peaked at $2.19M in Q1 2014.
  • 189 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.